using crypto, Featured snippets

The extremist organization claimed responsibility for the attack on the headquarters of the Afghan Refugee and Repatriation Affairs Department. On the 12th local time, the Islamic State khorasan province, a branch of the extremist organization, claimed responsibility for the attack on the headquarters of the Afghan Refugee and Repatriation Affairs Department. On the 11th, a suicide attack occurred at the headquarters of the Afghan Ministry of Refugees and Repatriation, which killed four people and seriously injured four others. Khalil Rahman Haqqani, Acting Minister of the Ministry of Refugees and Repatriation, died in the attack.Tsinghua University National Key Laboratory Base was established in Changping National Heavy Base at the end of the first phase. At present, Changping District is cooperating with Tsinghua University to build Tsinghua Nankou National Heavy Base, revitalizing the industrial remains of the "three major factories" in Nankou Town through urban renewal, and undertaking more than 14 national key laboratories in Tsinghua University. It is expected to be put into use in 2025, which will be the largest and most concentrated national key laboratory research base outside the main campus of Tsinghua University. Among them, two laboratories, Intelligent Green Vehicle and Transportation and New Power Operation and Control, will be completed and unveiled at the end of December this year. (Beijing Daily)The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.

According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.Laiyifen set up a business development company including integrated circuit business. The enterprise search APP shows that recently, Shanghai Laiyifen Future Domain Business Development Co., Ltd. was established, with the legal representative of Yu Ruifen and the registered capital of 1 million yuan. Its business scope includes: the second type of value-added telecommunications business; Internet information service; Communication equipment sales; Integrated circuit chips and product sales; Integrated circuit sales, etc. Enterprise investigation shows that the company is wholly owned by Laiyi.The Hang Seng Index rose more than 1%, the Hang Seng Technology Index rose 1.47%, and the technology stocks strengthened.

The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Market News: Brian Quintenz has become the top contender for the chairmanship of the Commodity Futures Trading Commission (CFTC).The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.